Prism Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.00 M
as on 24-10-2024
- Company Age 22 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
as on 24-10-2024
- Satisfied Charges ₹ 19.73 Cr
as on 24-10-2024
- Revenue 11.93%
(FY 2023)
- Profit 21607.00%
(FY 2023)
- Ebitda 4844.71%
(FY 2023)
- Net Worth 132.89%
(FY 2023)
- Total Assets 44.38%
(FY 2023)
About Prism Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹19.73 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Prism Life Sciences Limited India are Ajay Joshi as CFO and Shibu Kurup as Ceo. Shibu Kurup, Ajay Joshi, Vivek Batra, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH2002PLC137217
- Company No.
137217
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Sep 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Prism Life Sciences Limited offer?
Prism Life Sciences Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antifungal Injection, Tablet & Syrup, Hair Care, Hair Growth for Men, Baby Care, Baby Food.
Who are the key members and board of directors at Prism Life Sciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shibu Kurup  | Managing Director | 16-Sep-2002 | Current |
| Ajay Joshi | CFO | 08-Aug-2024 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajay Joshi | Director | 16-Sep-2002 | Current |
| Vivek Batra | Director | 30-Jun-2023 | Current |
| Neeta Shirke | Director | 08-Aug-2024 | Current |
Financial Performance of Prism Life Sciences.
Prism Life Sciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.93% increase. The company also saw a substantial improvement in profitability, with a 21607% increase in profit. The company's net worth Soared by an impressive increase of 132.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prism Life Sciences?
In 2023, Prism Life Sciences had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jaywin Remedies Private LimitedActive 36 years 8 monthsShibu Kurup, Ajay Joshi and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Jul 2023 | ₹2.00 Cr | Open |
Axis Bank Limited Creation Date: 26 Sep 2019 | ₹6.75 Cr | Satisfied |
Idbi Bank Limited Creation Date: 29 Oct 2008 | ₹4.74 Cr | Satisfied |
How Many Employees Work at Prism Life Sciences?
Prism Life Sciences has a workforce of 248 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prism Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prism Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
